CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 150 enrolled / 150 target
Drug / intervention
Observational Analysisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07580326
NCT07580326N/AActiveUpdate Overdue (6.0/mo)Completion was 17mo ago

Plastic Accumulation in Residual Brain Tissues From Hemorrhagic Events: Neurological Outcomes and Pathogenetic Evidence (PARTENOPE Study)

University of Campania Luigi Vanvitelli·observational·Posted May 12, 2026·Updated Jun 2, 2026

In Brief

An observational study evaluating Observational Analysis for Intracerebral Hemorrhage and Brain Hematoma. Active but no longer recruiting, targeting 150 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

This observational study investigates the presence of micro- and nanoplastics in surgically removed intracerebral hematomas and their association with neurological outcomes in patients with spontaneous intracerebral hemorrhage. Microplastics have recently been identified in human tissues and are increasingly recognized as potential contributors to inflammation and vascular dysfunction. However, their role in cerebrovascular diseases, particularly intracerebral hemorrhage, remains unknown. Patients undergoing surgical hematoma evacuation will be enrolled. Brain tissue and blood samples will be analyzed using advanced spectroscopic and imaging techniques to detect and characterize micro- and nanoplastics. The study aims to evaluate whether the presence of these particles is associated with increased inflammation, worse neurological outcomes, and higher risk of adverse cerebrovascular events. This research may provide novel insights into the impact of environmental pollutants on brain vascular disease and patient prognosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly

Timeline

N/AActiveOverdue
20252026
First PostedMay 12, 2026
Enrollment StartJun 1, 2024
Primary CompletionJan 1, 2025
Study CompletionJun 1, 2026
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 2 months ago

Arms & Interventions

Intracerebral Hemorrhage Patientsother

Patients with spontaneous intracerebral hemorrhage undergoing surgical hematoma evacuation. Micro- and nanoplastics will be measured in hematoma tissue and blood samples, and associations with clinical outcomes will be evaluated.

Other: Observational Analysis

Interventions

Observational Analysisother

No intervention is administered as part of the study. All patients receive standard clinical care according to current guidelines for intracerebral hemorrhage. Biological samples, including intracerebral hematoma tissue and peripheral blood, are collected for observational analysis of micro- and nanoplastics and their association with clinical, radiological, and biological outcomes.